Drugs / SV003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07469085 | Apr → Oct 2026 expected | — | Shanghai Synvida Biotechnology Co.,Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SV003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07469085 ↗ |